List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 125 studies with search of: Atrial Fibrillation and Stroke
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial
Conditions: Hypertension;   Atrial Fibrillation
Intervention: Device: AF Suppression Pacing Algorithm
2 Recruiting 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event
Conditions: Stroke;   Transient Ischemic Attack;   Atrial Fibrillation;   Atrial Flutter
Interventions: Device: a 30-day ambulatory cardiac event monitor;   Device: 24-hour Holter
3 Recruiting Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Flutter
Interventions: Drug: warfarin;   Drug: apixaban
4 Active, not recruiting Randomized, Double-Blind Study Comparing Once Daily Oral Rivaroxaban With Adjusted-Dose Oral Warfarin for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Warfarin
5 Active, not recruiting Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Warfarin
6 Completed Long-Term Safety in Atrial Fibrillation Patients
Conditions: Paroxysmal;   Persistent or Permanent Nonvalvular Atrial Fibrillation
Interventions: Drug: AZD0837;   Drug: Vitamin-K Antagonists (warfarin)
7 Recruiting Transesophageal Echocardiography to Identify pAtients With Low Risk of Stroke in Atrial Fibrillation - TIARA Pilot Study
Conditions: Atrial Fibrillation;   Stroke
Intervention: Procedure: Transoesophageal echocardiography
8 Recruiting Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: SSR126517E "biotinylated idraparinux";   Drug: warfarin
9 Completed Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: YM150;   Drug: warfarin
10 Recruiting A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic Acid (ASA)
11 Completed Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
Condition: Nonvalvular Atrial Fibrillation
Interventions: Drug: AZD0837;   Drug: Vitamin-K antagonist at INR 2-3
12 Recruiting Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
Conditions: Stroke;   Atrial Fibrillation;   Embolism
Interventions: Drug: warfarin tablets;   Drug: DU-176b tablets (high dose regimen);   Drug: DU-176b tablets (low dose regimen)
13 Not yet recruiting Left Atrial Appendage Occlusion Study II
Conditions: Atrial Fibrillation;   Stroke
Interventions: Procedure: Surgical occlusion of the left atrial appendage;   Procedure: Best medical practice
14 Recruiting WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke
Intervention: Device: WATCHMAN Left Atrial Appendage System
15 Completed Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etex;   Drug: Warfarin
16 Recruiting Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke
Conditions: Cryptogenic Symptomatic Transient Ischemic Attack;   Cryptogenic Ischemic Stroke
Intervention: Device: Reveal® XT Insertable Cardiac Monitor
17 Terminated Long-Term, Open-Label Follow-up Treatment of Patients With a-Fib Who Have Been Previously Treated With BIBR 1048
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Intervention: Drug: Dabigatran etexilate
18 Recruiting Cryptogenic Stroke Study
Condition: Cryptogenic Stroke
Intervention: Device: Sleuth AT Implantable ECG Monitoring System
19 Completed Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)
Conditions: Atrial Fibrillation;   Cardiovascular Disease
Interventions: Drug: Irbesartan;   Drug: placebo
20 Completed Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)
Conditions: Atrial Fibrillation;   Vascular Risk
Interventions: Drug: clopidogrel (SR25990C);   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services